CipherOx CRI Tablet
Adjunctive Cardiovascular Status Indicator
Flashback Technologies, Inc.
The following data is part of a De Novo classification by Flashback Technologies, Inc. with the FDA for Cipherox Cri Tablet.
Pre-market Notification Details
DeNovo ID | DEN160020 |
Device Name: | CipherOx CRI Tablet |
Classification | Adjunctive Cardiovascular Status Indicator |
Applicant | Flashback Technologies, Inc. 1215 Spruce Street, Suite 101 Boulder, CO 80302 |
Contact | Gordon Van Dusen |
Product Code | PPW |
CFR Regulation Number | 870.2200 [🔎] |
Decision | Granted (DENG) |
510(k) Premarket Notification | Device Classification Under Section 513(f)(2)(De Novo) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Lin |
Review Advisory Board | Cardiovascular |
Classification Advisory | Cardiovascular |
Type | Direct |
Date Received | 2016-05-24 |
Decision Date | 2016-12-21 |
FDA Review | Decision Summary |
Reclassification Order: | Reclassification Order |
NIH GUDID Devices
Device Identifier | submissionNumber | Supplement |
00860003025604 |
DEN160020 |
000 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.